Cannabis Science, Inc. (CBIS.OB) provided today the new photographs of the existing treatment for patient three who has a “worst case” of treatment resistant, Squamous Cell Carcinoma. Cannabis Science has received positive feedback from both the patient and his Oncologist. These photos show the progressive reduction of the tumor masses that has occurred within the months of treatment.
Since Cannabis Science has been working with this patient extensively, Dr. Robert Melamede has provided lots of support and expert scientific advice during the treatment process. Patient three came to Cannabis Science with hope to find a treatment that would work. Due to his extremely severe case of squamous cell carcinoma, his surgeon wanted to remove his scalp and a good portion of his skull. Instead he opted for 135 radiation treatments, but the remaining tumors became radiation and chemotherapy resistant. Dr. Robert Melamede informs that:
Cannabis extracts have the unique ability to holistically improve health. They simultaneously modify numerous biochemical pathways to produces a healthy concerted action.
Cannabis Science Inc.
6946 North Academy Blvd
Suite B #254
Colorado Springs, CO 80918
Contact: Dr. Robert J. Melamede, President & CEO
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development.
Gamma Pharmaceuticals, Inc. (GMPM.PK) reached a milestone in its strategic plan for the current fiscal year: The Company has accepted its first order for a Male Enhancement product for export to Mexico.
Gamma’s customer is a large commercial operation in Mexico with distribution coverage and access to more than 15,000 retail locations. The contract governing this relationship has a two-year term with automatic extensions, creating a long term opportunity for Gamma in this important market. A full range of Gamma’s products are under discussion and commercial review is underway.
Separately, Gamma is announcing it has developed a proprietary, fast acting Male Enhancement oral GEL and is in the late stages of product testing.
Joseph Cunningham, Gamma’s President commented:
Gamma’s focus on alternative delivery systems for everyday health and wellbeing make the Male Enhancement market a natural opportunity for our proprietary knowledge and expertise. We are very excited to begin our export program to Mexico and beyond. We anticipate strong growth in this category and expansion of the product mix in the months ahead.
Gamma Pharmaceuticals, Inc.
2569 East Washburn Road North
Las Vegas, NV 89081
Joe Cunningham, President
Tel: (651) 204 2048
Gamma Pharmaceuticals Inc, is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers both in the US and internationally. Gamma’s core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in Greater China and the United States.
Breezer Ventures Inc. (BRZV) annonced yesterday after trading hours that it is making a significant step forward in its growth strategy to develop its Texas oil and gas assets. The Company has entered into a joint venture to develop the Jackson Oil and Gas Leases into production with Firecreek Global Inc. (Firecreek) and Tristar Energy Group Inc. (Tristar).
Breezer, Firecreek and Tristar have agreed to work together closely to embark on an active drilling program in the Jackson Oil and Gas play. It is a three phase work program totaling $2,475,000 in work expenditures; the first phase scheduled to commence April 20, 2012. Tristar will be responsible for funding $1,875,000 and the balance of $600,000 will be prorated between the working interests’ owners. Firecreek will be the Operator through all phases of the program. Tristar will earn up to a 50% working interest, Global will earn up to 6/16th working interest and Breezer will earn a 1/16th working interest in all the wells to be developed.
Breezer Ventures . (OTC:BRZV) is a publicly traded independent emerging natural resources company. The company’s focus is on the acquisition, exploration, development and production of oil, natural gas and minerals. We believe that the world has entered a commodities super cycle caused by globalization and the industrialization of large emerging countries and regions such as India, China and the Middle East. Our objective is to find, acquire and develop natural resources at the lowest cost possible and recycle our cash flows into new projects yielding the highest returns with controlled risk.